Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Chesapeake Utilities Corporation designated Jeffrey S. Sylvester as the company's principal financial officer and Michael D. Galtman as the principal accounting officer. Mr. Sylvester continues to serve as CFO, while Mr. Galtman continues as Chief Transformation Officer; no changes to their compensation were made in connection with these designations.
AVAX ONE TECHNOLOGY LTD. appointed Stephanie Brady as Chief Accounting Officer, effective August 19, 2026. Ms. Brady will serve via a consulting agreement with Nanook & Company, LLC, receiving a monthly cash fee of $20,000 through an initial term ending December 31, 2027.
Bayview Acquisition Corp received notice that the Nasdaq Listing and Hearing Review Council affirmed a prior decision to delist the company's securities. The delisting stems from the company's failure to complete its business combination with Oabay Inc. by the June 19, 2026 deadline. The company intends to transition the listing of its ordinary shares and rights to the OTC Pink Market.
Lakewood-Amedex Biotherapeutics held its 2026 Annual Meeting where stockholders elected four directors and approved several key proposals. These included increasing authorized common shares from 12.5 million to 100 million, authorizing a potential reverse stock split at a ratio of up to 1-for-20, and increasing shares issuable under the 2020 Equity Incentive Plan to 400,000.
AIxCrypto Holdings M&A Deal with Faraday Future Intelligent Electric Inc.
AIxCrypto Holdings, Inc. entered into a non-binding term sheet to acquire the robotics business (RobotCo) from its majority stockholder, Faraday Future Intelligent Electric Inc. (FFAI). The proposed transaction is being reviewed by a Special Committee of independent directors due to its related-party nature and remains subject to the negotiation of definitive agreements and a fairness opinion.
National Healthcare Properties Divestiture to unaffiliated third party for $531M
National Healthcare Properties, Inc. announced that certain termination rights have expired under a purchase and sale agreement to sell its portfolio of 40 outpatient medical facilities for approximately $531 million. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.
Prospect Floating Rate & Alternative Income Fund Dividend
Prospect Floating Rate and Alternative Income Fund declared a monthly base distribution of $0.03242 per share and a quarterly bonus distribution of $0.04333 per share for September 2026. The combined distributions represent a total annualized yield of 14.46% based on the Fund's June 30, 2026 net asset value of $3.89 per share. Both distributions are payable on October 7, 2026, to stockholders of record as of September 30, 2026.
Polar Power entered into an exchange agreement with its CEO, Arthur Sams, who surrendered $614,700 in promissory notes and accrued interest in exchange for 683 shares of Series A Convertible Preferred Stock and a warrant to purchase 382,276 shares of common stock. This debt-for-equity swap is intended to strengthen the company's balance sheet and assist in regaining compliance with Nasdaq's minimum stockholders' equity requirements.
Clearway Energy Signs $230M M&A Deal with Swan CE Seller LLC
Clearway Energy LLC's subsidiary, Swan Purchaser LLC, entered into a definitive agreement to acquire membership interests in Swan TargetCo LLC for approximately $230 million. The target company will indirectly own Swan Solar LLC, which is developing a 650-megawatt solar facility in Bates County, Missouri. The transaction is expected to close in the third quarter of 2028.
Newbury Street II Acquisition Corp announced it will hold an extraordinary general meeting (EGM) in lieu of an annual general meeting to satisfy Nasdaq's annual meeting requirement. Shareholders seeking to bring business before the EGM must deliver proposals to the company no later than October 8, 2026. The meeting is required to be held on or prior to December 31, 2026, under Nasdaq Listing Rule 5620(a).
Clearway Energy Signs $230M M&A Deal with Swan CE Seller LLC
Clearway Energy, through its subsidiary Swan Purchaser LLC, has entered into a definitive agreement to acquire membership interests in Swan TargetCo LLC for approximately $230 million in cash. The target company will indirectly own Swan Solar LLC, which is developing a 650-megawatt solar facility in Bates County, Missouri. The transaction is expected to close in the third quarter of 2028, subject to customary conditions.
Glucotrack Debt Financing Update with September Investors
Glucotrack, Inc. entered into amendments for its senior secured convertible promissory notes and various common stock purchase warrants issued in July, August, and September 2026. The amendments primarily remove downward adjustments to the Floor Price and mandate that make-whole payments be satisfied only in cash, while the company also confirmed the full repayment of its July Bridge Notes.
Surf Air Mobility appointed Jason Secore as Chief Financial Officer, effective September 30, 2026, succeeding Oliver Reeves. Secore, who previously served as CFO of Matternet, will receive a base salary of $450,000 and an equity package consisting of 260,000 RSUs and 530,000 PRSUs. Reeves will remain with the company as an advisor through September 2027 to ensure a smooth transition.
Anavex Life Sciences Corp. held its 2026 Annual Meeting of Stockholders on September 24, 2026, where a contested election resulted in the appointment of new directors. The election triggered a 'change in control' provision under the company's incentive plans because incumbent directors no longer constitute a majority of the board, resulting in the immediate vesting of all outstanding unvested equity awards.
Viking Therapeutics closed a public equity offering of 9,035,714 shares of common stock at $35.00 per share, including the full exercise of the underwriters' overallotment option. The company raised approximately $297.0 million in net proceeds from the equity portion. Simultaneously, the company issued $258.75 million in 2.00% Convertible Senior Notes due 2032 to further strengthen its balance sheet.
Value
$316M
Counterparty
Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC
Sabre $1.35B Debt Financing with Wilmington Trust, National Association
Sabre Corporation's subsidiary, Sabre Financial Borrower, LLC, issued $1.35 billion in 9.875% Senior Secured Notes due 2032. The proceeds were used to refinance existing debt, including prepaying an intercompany loan and repurchasing approximately $1.18 billion in outstanding senior secured notes due 2029 through cash tender offers.
Ameren Missouri filed its 2026 Integrated Resource Plan (IRP) with the Missouri Public Service Commission, outlining a preferred plan to meet projected energy demand growth of up to 9 GW by 2045. The plan includes significant investments in natural gas-fired generation, solar, wind, battery storage, and new nuclear generation, while extending the life of certain coal units and retiring others. Key targets include adding 2,100 MW of combined-cycle gas by 2031 and 2,400 MW of battery storage by 2030.
CNL Strategic Residential Credit, Inc. declared a monthly cash distribution of $0.166667 per share for both Class E and Class FA common stock, payable on September 28, 2026. The company also updated its Net Asset Value (NAV) per share to $24.95 for Class E and $24.26 for Class FA as of August 31, 2026. Additionally, the Board approved new offering prices for its private offering based on these NAV figures.
AST SpaceMobile adopted a Senior Management Change of Control Severance Policy for its CEO, President, and senior executives. The policy provides lump-sum cash payments (2.0x salary/bonus for CEO, 1.5x for others) and accelerated vesting of equity awards if executives are terminated without cause or resign for constructive discharge following a change of control. This arrangement is designed to ensure management stability and focus during potential acquisition scenarios.
Kodiak Gas Services M&A Deal with Distributed Power Solutions, LLC
Kodiak Gas Services, Inc. filed an amendment to provide pro forma financial information regarding its previously completed acquisition of Distributed Power Solutions, LLC (DPS). The filing includes unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2026, treating the acquisition as if it had occurred on January 1, 2025.
Kodiak Gas Services, Inc. filed a Certificate of Elimination to its Amended and Restated Certificate of Incorporation to eliminate all matters related to its Series A Preferred Stock. The company stated that no shares of the Series A Preferred Stock are currently outstanding and no further shares will be issued under the previous Certificate of Designation.
Nexalin Technology received a notification from the Nasdaq Hearings Panel granting a conditional extension to regain compliance with listing standards. The company must demonstrate a minimum bid price of $1.00 for 20 consecutive trading sessions by September 28, 2026, and meet the $2.5 million stockholders' equity requirement by January 4, 2027.
Exascale Labs Holdings reported fiscal year 2026 revenue of $14.8 million, a 111% increase year-over-year driven by its GPU-as-a-Service platform. The company also highlighted its recent Nasdaq listing following a business combination and the appointment of a new CFO.
Term
FY2026
“Fiscal year 2026 was the year we laid the foundation to become a public company. To establish our readiness for this next phase, we grew our GPU-as-a-Service business, deepened our infrastructure partnership with Compal, and closed the agreement that brought Exascale to Nasdaq.”
Hoansoo Lee, Chief Executive Officer
“Exascale’s revenue grew 111% this past fiscal year, powered by a 124% increase in our intelligent computing power service and a customer renewal rate around 68%, and the balance sheet is now stronger following the close of the business combination.”
CervoMed announced pharmacokinetic and regulatory updates for its lead drug candidate, neflamapimod, including a new 50 mg oral tablet formulation and the FDA's removal of a previous drug exposure limit. These developments allow the company to advance a 100 mg twice-daily dosing regimen in future clinical trials, which is expected to achieve higher drug concentrations and improve patient convenience compared to prior three-times-daily dosing.
U S Physical Therapy $171M Debt Financing with Bank of America, National Association
U.S. Physical Therapy, Inc. entered into a 45-month forward-starting interest rate swap agreement with Bank of America with an initial notional amount of $170.6 million. The swap fixes the variable interest rate on the company's existing term debt at 4.578% per annum effective June 30, 2027, through April 14, 2031. This transaction is designed to hedge interest rate risk associated with the company's Fourth Amended and Restated Credit Agreement.
Accendra Health announced that Kenneth Gardner-Smith will assume the role of President and CEO on October 5, 2026, succeeding Edward A. Pesicka. Mr. Pesicka will retire from the Board and enter into a 30-month consulting agreement to ensure a smooth transition, during which his existing equity awards will continue to vest.
Faraday Future Intelligent Electric Divestiture to AIxCrypto Holdings, Inc for $200M
Faraday Future Intelligent Electric Inc. entered into a non-binding term sheet to sell its robotics business to its majority-owned subsidiary, AIxCrypto Holdings, Inc., for $200 million. The consideration will be paid in AIxC common and non-voting convertible preferred stock, and the transaction is being reviewed by a Special Committee of the Board due to its related-party nature.
NeOnc Technologies has scheduled an in-person End-of-Phase 1 Type B meeting with the FDA for November 17, 2026, to discuss the clinical development of NEO212. The company intends to seek feedback on Phase 2 study design, patient populations, and potential accelerated approval pathways following encouraging Phase 1 results in glioblastoma and brain metastases.
San Juan Basin Royalty Trust provided an operational update regarding administrative expenses and the conclusion of a 2017–2020 joint interest audit. The Trustee reported a $976,000 year-over-year decrease in G&A expenses following the transition to Argent Trust Company and determined that pursuing further recovery from the Hilcorp audit was not cost-effective.
Inhibrx Biosciences, Inc. has updated its corporate investor presentation, which is being used for meetings and conferences with the investment community. The presentation provides a summary of the company's business strategy and clinical pipeline updates for its investigational product candidates.